CVE:THCX - Hydropothecary Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
C$5.30 +0.33 (+6.64 %)
(As of 07/20/2018 04:00 PM ET)
Previous CloseC$5.30
Today's RangeC$5.00 - C$5.37
52-Week RangeC$1.10 - C$5.42
Volume5.38 million shs
Average Volume2.35 million shs
Market CapitalizationC$718.94 million
P/E RatioN/A
Dividend YieldN/A
The Hydropothecary Corporation, together with its subsidiaries, produces and distributes medical marijuana products. The company is headquartered in Gatineau, Canada.

Receive THCX News and Ratings via Email

Sign-up to receive the latest news and ratings for THCX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange CVE
Industry Drug Manufacturers - Specialty & Generic


Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A


Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A


EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins-174.14%
Return on Equity-24.09%
Return on Assets-13.50%


Outstanding Shares179,077,000
Market CapC$718.94

Hydropothecary (CVE:THCX) Frequently Asked Questions

What is Hydropothecary's stock symbol?

Hydropothecary trades on the Canadian Venture Exchange (CVE) under the ticker symbol "THCX."

What price target have analysts set for THCX?

2 Wall Street analysts have issued 12 month price objectives for Hydropothecary's stock. Their forecasts range from C$3.50 to C$9.50. On average, they anticipate Hydropothecary's stock price to reach C$6.25 in the next year. This suggests a possible upside of 17.9% from the stock's current price. View Analyst Ratings for Hydropothecary.

What is the consensus analysts' recommendation for Hydropothecary?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Hydropothecary in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy."

Who are some of Hydropothecary's key competitors?

Who are Hydropothecary's key executives?

Hydropothecary's management team includes the folowing people:
  • Mr. Sebastien G. St-Louis, Co-Founder, Pres, CEO & Director (Age 34)
  • Mr. Adam Miron, Co-founder, Chief Brand Officer & Director (Age 34)
  • Mr. Ed Chaplin, CFO & Corp. Sec. (Age 48)
  • Mr. James McMillan, VP of Bus. Devel. (Age 50)
  • Mr. Arno Groll, Director of Operations

Has Hydropothecary been receiving favorable news coverage?

Media headlines about THCX stock have trended somewhat positive this week, Accern Sentiment reports. Accern identifies negative and positive press coverage by monitoring more than twenty million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Hydropothecary earned a daily sentiment score of 0.21 on Accern's scale. They also gave press coverage about the company an impact score of 44.77 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the next several days.

How do I buy shares of Hydropothecary?

Shares of THCX and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

What is Hydropothecary's stock price today?

One share of THCX stock can currently be purchased for approximately C$5.30.

How big of a company is Hydropothecary?

Hydropothecary has a market capitalization of C$718.94 million.

How can I contact Hydropothecary?

Hydropothecary's mailing address is 120 Ch de la Rive, GATINEAU, QC J8M 1V2, Canada. The company can be reached via phone at +1-416-7504949.

MarketBeat Community Rating for Hydropothecary (CVE THCX)

Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  48 (Vote Outperform)
Underperform Votes:  35 (Vote Underperform)
Total Votes:  83
MarketBeat's community ratings are surveys of what our community members think about Hydropothecary and other stocks. Vote "Outperform" if you believe THCX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe THCX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/21/2018 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.